Timothy Rolph

Timothy Rolph

Founder at AKERO THERAPEUTICS, INC.

Net worth: 5 M $ as of 31/03/2024

70 year
Health Technology
Consumer Services
Finance

Profile

Timothy Rolph is the founder of Akero Therapeutics, Inc. which is founded in 2017, where he is currently the Chief Scientific Officer.
He held the position of Senior Vice President-Program Value Enhancement at Pfizer Inc. from 1994 to 2016.
From 2016 to 2018, he was a Partner at Apple Tree Venture Management Llc.
He was also the Chief Scientific Officer at Cardiovascular Group from 2014 to 2016.
Mr. Rolph was the Head-Research at Veldhoven UK Ltd.
Mr. Rolph holds a doctorate from the University of Oxford and an undergraduate degree from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/03/2024 182,558 ( 0.26% ) 5 M $ 31/03/2024

Timothy Rolph active positions

Former positions of Timothy Rolph

CompaniesPositionEnd
Corporate Officer/Principal 01/09/2018
PFIZER, INC. Corporate Officer/Principal 01/10/2016
Corporate Officer/Principal 01/10/2016
Corporate Officer/Principal -
See the detail of Timothy Rolph's experience

Training of Timothy Rolph

University of Oxford Doctorate Degree
University of London Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Timothy Rolph's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PFIZER, INC.

Health Technology

AKERO THERAPEUTICS, INC.

Health Technology

Private companies3

Finance

Health Services

Distribution Services

See company connections